Insights
Thinking at the intersection of women’s health, science, and leadership.
Writing, interviews, and conversations exploring women’s health, FemTech, ethical innovation, and leadership in healthcare.
In this article, Roswitha examines why less than 0.5% of healthcare VC reaches women's health and how funding structure shapes femtech validation rigor and investor trust.
What does it mean to build femtech that works for every woman?
A framework for inclusive validation, algorithmic fairness, and evidence-based reproductive health technology.
Roswitha Verwer on why femtech keeps failing the women who need it most, and what human-centered, culturally responsive co-design actually requires to change that.
Discover why an ethical, connected, and privacy-preserving data infrastructure is essential for building trust in FemTech and women’s reproductive healthcare.
Roswitha Verwer explores whether the term FemTech helps or limits women’s healthcare, and why the future must move beyond visibility toward full integration in mainstream medicine.
Roswtha Verwer explores how delayed diagnosis in reproductive health drives emotional, financial, and clinical costs, and how earlier biological insight can reduce failed fertility cycles and unnecessary escalation.
Roswitha Verwer shares why YON E is closing its seed readiness round, how funding will support prototype completion, clinical trial preparation, regulatory readiness, and the next phase of women’s health diagnostics.
YON E is preparing for launch by listening first. Through voice-of-customer research with 400+ women, clinician conversations, community engagement, and pricing validation, we are building a women’s health platform rooted in real demand, clinical relevance, and objective daily insights into cycle, fertility, and vaginal health.
Roswitha Verwer explores why women’s health remains reactive and symptom-based, and how continuous physiological signals like temperature and vaginal health can provide real insight. Understanding patterns over time enables better fertility awareness, earlier intervention, and more informed care decisions.
Trust is not a feature in women’s health; it is the foundation.
This article explores why transparency, data ownership, and clinical integrity are essential for adoption in femtech. Discover how YON E is redefining women’s health technology by prioritizing safety, clarity, and user control, because without trust, even the most advanced solutions fail.
Preventive women’s health is entering a new era.
Roswitha Verwer explains how biosensors, personalized medicine, and cultural change are making hormonal and reproductive health measurable, empowering women and clinicians with data-driven insights.
Integrity in women’s healthcare is not a marketing choice; it is a responsibility.
In this powerful reflection, Roswitha Verwer shares why transparency, honesty, and moral clarity must define FemTech innovation and leadership, and how YON E is setting a new standard for trust, data ethics, and women-centered care.
Roswitha Verwer explains why women’s health technology must put values before profit.
Discover how trust, empowerment, and inclusive design are reshaping femtech and improving healthcare outcomes for women.
Femtech adoption depends on trust and emotional safety, not only clinical validation. This article shows how UX design, branding, and patient experience influence engagement in vaginal health and fertility tech.
Women’s bodies weren’t the standard in medical research and women’s health still pays the price. This article explains how male-default clinical trials drive misdiagnosis and uneven drug response, and why femtech + inclusive health data can enable personalized care.
This article explains why trust is the missing infrastructure in women’s health: femtech must prioritize ongoing consent and data transparency so women feel safe to engage and research can finally improve care and pharma outcomes.
Women’s health innovation must start with real life, not labs. This article explores why listening to women, tracking real biomarkers, and breaking taboos is essential for preventive, science based care and better clinical outcomes.
Roswitha Verwer and Dr. Muskaan Bhan share their journey from preclinical validation through regulatory approval, currently at TRL4, pursuing CE Mark and FDA De Novo. The conversation offers insights into how real-time biomarker data can transform women’s reproductive health while overcoming investor skepticism, taboo, and market barriers when solving decades-old clinical blind spots in women’s health.
“Roswitha Verwer en YON E Health bouwen aan een nieuwe generatie FemTech-innovatie door real-time data over vaginale gezondheid toegankelijk te maken voor vrouwen.”
“The investment will support the development of YON E Health’s smart vaginal health device that measures pH and temperature, two biomarkers linked to fertility, infection risk, and reproductive health.”
Peter Kovacs features Roswitha Verwer and Muskaan Bhan on Clinical Capital Conversations, exploring how she scales FemTech with precision, purpose, and science-driven innovation in women’s health.
“YON E Health has raised pre-seed funding led by PMK-Group to advance its smart vaginal health device, tracking pH and temperature for fertility, infection risk, and reproductive wellness, as Europe’s FemTech sector gains momentum with data-driven, clinical-grade innovation.”
“Yon E Health has raised €250k in pre-seed funding to develop a smart vaginal health sensor measuring pH and temperature, helping women track fertility, infection risk, and reproductive wellbeing with real-time, clinical-grade data ahead of medical trials”
“YON E Health has raised pre-seed funding led by PMK-Group to advance its smart vaginal health device, tracking pH and temperature for fertility, infection risk, and reproductive wellness, as Europe’s FemTech sector gains momentum with data-driven, clinical-grade innovation.”
“YON E Health has raised €250,000 in pre-seed funding to develop an at-home device measuring vaginal pH and temperature, helping women track fertility, infection risk, and reproductive health with real-time, science-backed insights.”
“YON E Health raises €250k pre-Seed to advance a first-of-its-kind smart vaginal health device measuring pH and temperature for fertility, infection risk, and reproductive wellbeing, strengthening Europe’s growing FemTech market with science-backed, women-centered innovation.”
YON E Health has raised €250k in pre-seed funding to advance its vaginal health device, highlighting growing investor interest in European femtech and smarter women’s health solutions designed to improve monitoring, prevention and personalised reproductive care.
“Roswitha Verwer, CEO of YON E Health, is building data-driven solutions to transform women’s health. Driven by lived experience, she is breaking taboos in vaginal health and fertility, turning real-time biomarker insights into personalized care for women worldwide.”
“Roswitha Verwer, CEO of YON E Health, is pioneering data-driven innovation in women’s health. She leads the development of a smart vaginal health device, transforming taboo topics into real-time insights for fertility, prevention, and personalized care.”
YON E Health was highlighted by Founders Amplified for its medical device innovation advancing vaginal health data, FemTech research, and stigma-free women’s healthcare.
Founder Roswitha Verwer shares insights on FemTech, vaginal health innovation, fertility awareness, resilience, and values-driven leadership on the Productive Passions Podcast.
Explores the “female paradox” (women live longer yet spend more life in poor health), the economic cost of the women’s health gap, and why the European Femtech Map was created, tracking 10 femtech categories and where companies and communities are growing fastest.
Roswitha Verwer, Founder of YON E Health, joins The Founders Atlas podcast to discuss FemTech innovation, reproductive health data, and building a mission-driven women’s health startup.
YON E founder Roswitha Verwer brings FemTech into medical education at Semmelweis University, reshaping women’s health innovation and STEM.
Interview with Roswitha Verwer, founder of YON E Global, on building a patent-pending femtech device, launching a European femcare webshop, and navigating funding challenges in women’s health. Covers mission, milestones, and global growth in digital health.
Speaking
Keynotes, panels, and moderated conversations on women’s health, ethical innovation, and leadership in healthcare.
Contact
Professional inquiries, collaborations, and media requests.